Skip to main content
. 2022 Feb 21;10(2):340. doi: 10.3390/vaccines10020340

Figure 5.

Figure 5

Anti-ShigETEC IgA responses in ALS and stool extracts. (A) anti-ShigETEC IgA responders in ALS (B) anti-ShigETEC IgA responders in stool extracts from available samples with sufficient total IgA content to allow comparison of samples collected at different time points from the same subject (C) Pearson correlation between fecal and serum IgA titer increases detected by ELISA using ShigETEC lysate as antigen with samples of individuals in the three-dose (square) and four-dose (circle) groups.